Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.BO)

INR 44.27

(0.52%)

Total Liabilities Summary of Biofil Chemicals and Pharmaceuticals Limited

  • Biofil Chemicals and Pharmaceuticals Limited's latest annual total liabilities in 2023 was 288.79 Million INR , up 104.76% from previous year.
  • Biofil Chemicals and Pharmaceuticals Limited's latest quarterly total liabilities in 2023 FY was 288.79 Million INR , up 104.76% from previous quarter.
  • Biofil Chemicals and Pharmaceuticals Limited reported annual total liabilities of 141.04 Million INR in 2022, up 644.48% from previous year.
  • Biofil Chemicals and Pharmaceuticals Limited reported annual total liabilities of 18.94 Million INR in 2021, down -88.93% from previous year.
  • Biofil Chemicals and Pharmaceuticals Limited reported quarterly total liabilities of 245.45 Million INR for 2023 Q2, down 0.0% from previous quarter.
  • Biofil Chemicals and Pharmaceuticals Limited reported quarterly total liabilities of 288.79 Million INR for 2023 FY, up 104.76% from previous quarter.

Annual Total Liabilities Chart of Biofil Chemicals and Pharmaceuticals Limited (2023 - 2008)

Historical Annual Total Liabilities of Biofil Chemicals and Pharmaceuticals Limited (2023 - 2008)

Year Total Liabilities Total Liabilities Growth
2023 288.79 Million INR 104.76%
2022 141.04 Million INR 644.48%
2021 18.94 Million INR -88.93%
2020 171.09 Million INR -37.74%
2019 274.81 Million INR 160.16%
2018 105.63 Million INR -3.86%
2017 109.87 Million INR 20.16%
2016 91.43 Million INR -30.86%
2015 132.25 Million INR 147.59%
2014 53.41 Million INR -20.7%
2013 67.35 Million INR 9.87%
2012 61.3 Million INR -15.7%
2011 72.72 Million INR 97.67%
2010 36.79 Million INR -56.84%
2009 85.24 Million INR 18.42%
2008 71.98 Million INR 0.0%

Peer Total Liabilities Comparison of Biofil Chemicals and Pharmaceuticals Limited

Name Total Liabilities Total Liabilities Difference
Alkem Laboratories Limited 48.6 Billion INR 99.406%
Amrutanjan Health Care Limited 783.82 Million INR 63.155%
Alembic Pharmaceuticals Limited 16.27 Billion INR 98.225%
AstraZeneca Pharma India Limited 3.66 Billion INR 92.112%
Aurobindo Pharma Limited 152.2 Billion INR 99.81%
Eris Lifesciences Limited 38.26 Billion INR 99.245%
FDC Limited 3.7 Billion INR 92.214%
Glenmark Life Sciences Limited 5.18 Billion INR 94.426%
Ipca Laboratories Limited 33.74 Billion INR 99.144%
Jagsonpal Pharmaceuticals Limited 296.76 Million INR 2.683%
Krebs Biochemicals & Industries Limited 2.97 Billion INR 90.289%
Laurus Labs Limited 42.71 Billion INR 99.324%
Lupin Limited 96.23 Billion INR 99.7%
Medicamen Biotech Limited 940.36 Million INR 69.289%
Medico Remedies Limited 438.24 Million INR 34.101%
Megasoft Limited 1.85 Billion INR 84.416%
NATCO Pharma Limited 10.53 Billion INR 97.258%
Piramal Pharma Limited 74 Billion INR 99.61%
Sigachi Industries Limited 2.53 Billion INR 88.591%
Solara Active Pharma Sciences Limited 14.14 Billion INR 97.958%
Sun Pharmaceutical Industries Limited 183.56 Billion INR 99.843%
Suven Pharmaceuticals Limited 2.03 Billion INR 85.803%
Syncom Formulations (India) Limited 1.16 Billion INR 75.215%
Themis Medicare Limited 1.88 Billion INR 84.699%
Torrent Pharmaceuticals Limited 82.05 Billion INR 99.648%
Valiant Laboratories Limited 1.05 Billion INR 72.71%
Wanbury Limited 3.15 Billion INR 90.848%
Windlas Biotech Limited 1.76 Billion INR 83.616%
ZIM Laboratories Limited 2.08 Billion INR 86.121%
Zydus Lifesciences Limited 71.79 Billion INR 99.598%
Ajanta Pharma Limited 10.71 Billion INR 97.304%
Ind-Swift Laboratories Limited 2.28 Billion INR 87.386%
Achyut Healthcare Limited 2.01 Million INR -14246.696%
Lasa Supergenerics Limited 541.92 Million INR 46.709%
Sun Pharma Advanced Research Company Limited 3.89 Billion INR 92.581%
Aarti Pharmalabs Limited 8.25 Billion INR 96.5%
Alpa Laboratories Limited 307.12 Million INR 5.966%
Gufic Biosciences Limited 5.59 Billion INR 94.843%
Ind-Swift Limited 13.45 Billion INR 97.853%
Indoco Remedies Limited 10.34 Billion INR 97.208%
Hester Biosciences Limited 3.59 Billion INR 91.966%
Bliss GVS Pharma Limited 2.1 Billion INR 86.305%
Bajaj HealthCare Limited 4.86 Billion INR 94.067%
RPG Life Sciences Limited 1.38 Billion INR 79.076%
Mankind Pharma Limited 23.87 Billion INR 98.79%
Glenmark Pharmaceuticals Limited 65.11 Billion INR 99.556%
Unichem Laboratories Limited 8.06 Billion INR 96.421%
Bal Pharma Limited 2.51 Billion INR 88.5%
Strides Pharma Science Limited 37.68 Billion INR 99.234%
Venus Remedies Limited 1.39 Billion INR 79.265%
Jubilant Pharmova Limited 61.27 Billion INR 99.529%
Dr. Reddy's Laboratories Limited 106.96 Billion INR 99.73%
Divi's Laboratories Limited 18.99 Billion INR 98.479%
Nectar Lifesciences Limited 11.21 Billion INR 97.426%
Shilpa Medicare Limited 12.93 Billion INR 97.767%
Aarti Drugs Limited 11.5 Billion INR 97.49%
IOL Chemicals and Pharmaceuticals Limited 6.32 Billion INR 95.437%
Suven Life Sciences Limited 148.62 Million INR -94.319%
J. B. Chemicals & Pharmaceuticals Limited 10.7 Billion INR 97.303%
Hikal Limited 12.99 Billion INR 97.778%
Procter & Gamble Health Limited 2.56 Billion INR 88.724%
Sequent Scientific Limited 8.27 Billion INR 96.51%
Novartis India Limited 1.8 Billion INR 83.965%
Granules India Limited 22.95 Billion INR 98.742%
Wockhardt Limited 39.87 Billion INR 99.276%
Brooks Laboratories Limited 248.6 Million INR -16.17%
Neuland Laboratories Limited 5.49 Billion INR 94.748%
Morepen Laboratories Limited 4.45 Billion INR 93.524%
Kilitch Drugs (India) Limited 643.88 Million INR 55.147%
Mangalam Drugs & Organics Limited 1.97 Billion INR 85.387%